Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Robert B. Parker, PharmD
Articles
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation
Christina A. Spivey, PhD;Xianchen Liu, MD, PhD;Yanru Qiao, MS;Jack Mardekian, PhD;Robert B. Parker, PharmD;Hemant Phatak, PhD;Cristina Masseria, PhD;Sumesh Kachroo, PhD;Younos Abdulsattar, P
August 18th 2016This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
